ZWJ Investment Counsel’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,372
| Closed | -$269K | – | 229 |
|
|
2024
Q1 | $269K | Sell |
3,372
-1,000
| -23% | -$76.4K | 0.01% | 200 |
|
|
2023
Q4 | $345K | Sell |
4,372
-96
| -2% | -$6.83K | 0.02% | 156 |
|
|
2023
Q3 | $312K | Sell |
4,468
-859
| -16% | -$60.9K | 0.02% | 154 |
|
|
2023
Q2 | $368K | Sell |
5,327
-459
| -8% | -$32.7K | 0.02% | 142 |
|
|
2023
Q1 | $430K | Sell |
5,786
-1,151
| -17% | -$96.5K | 0.02% | 137 |
|
|
2022
Q4 | $646K | Hold |
6,937
| – | – | 0.04% | 119 |
|
|
2022
Q3 | $662K | Sell |
6,937
-121
| -2% | -$12K | 0.04% | 109 |
|
|
2022
Q2 | $654K | Buy |
7,058
+2,943
| +72% | +$287K | 0.04% | 117 |
|
|
2022
Q1 | $416K | Sell |
4,115
-4,116
| -50% | -$432K | 0.02% | 132 |
|
|
2021
Q4 | $849K | Sell |
8,231
-416
| -5% | -$38.4K | 0.04% | 106 |
|
|
2021
Q3 | $734K | Sell |
8,647
-313
| -3% | -$26.2K | 0.04% | 111 |
|
|
2021
Q2 | $748K | Hold |
8,960
| – | – | 0.04% | 110 |
|
|
2021
Q1 | $674K | Sell |
8,960
-1,551
| -15% | -$113K | 0.04% | 113 |
|
|
2020
Q4 | $718K | Buy |
10,511
+6,006
| +133% | +$391K | 0.05% | 104 |
|
|
2020
Q3 | $263K | Hold |
4,505
| – | – | 0.02% | 131 |
|
|
2020
Q2 | $293K | Sell |
4,505
-55
| -1% | -$3.46K | 0.03% | 125 |
|
|
2020
Q1 | $271K | Buy |
4,560
+275
| +6% | +$18.4K | 0.02% | 175 |
|
|
2019
Q4 | $318K | Buy |
4,285
+336
| +9% | +$23.6K | 0.02% | 181 |
|
|
2019
Q3 | $249K | Buy |
+3,949
| New | +$234K | 0.02% | 142 |
|
|
2018
Q4 | – | Sell |
-2,906
| Closed | -$229K | – | 166 |
|
|
2018
Q3 | $229K | Buy |
+2,906
| New | +$208K | 0.02% | 149 |
|
|
2018
Q1 | – | Sell |
-12,562
| Closed | -$911K | – | 187 |
|
|
2017
Q4 | $911K | Sell |
12,562
-282,540
| -96% | -$20.5M | 0.07% | 117 |
|
|
2017
Q3 | $24M | Sell |
295,102
-5,422
| -2% | -$429K | 1.87% | 16 |
|
|
2017
Q2 | $24.2M | Buy |
300,524
+2,158
| +0.7% | +$170K | 1.93% | 17 |
|
|
2017
Q1 | $23.4M | Buy |
298,366
+172,111
| +136% | +$13.7M | 1.92% | 16 |
|
|
2016
Q4 | $9.96M | Buy |
126,255
+118,126
| +1,453% | +$9.56M | 0.96% | 45 |
|
|
2016
Q3 | $723K | Buy |
8,129
+230
| +3% | +$21.7K | 0.07% | 94 |
|
|
2016
Q2 | $756K | Hold |
7,899
| – | – | 0.08% | 96 |
|
|
2016
Q1 | $819K | Sell |
7,899
-105
| -1% | -$10.2K | 0.09% | 91 |
|
|
2015
Q4 | $783K | Buy |
8,004
+119
| +2% | +$11.7K | 0.09% | 93 |
|
|
2015
Q3 | $761K | Sell |
7,885
-100
| -1% | -$10.5K | 0.09% | 89 |
|
|
2015
Q2 | $837K | Sell |
7,985
-911
| -10% | -$93.1K | 0.09% | 89 |
|
|
2015
Q1 | $918K | Hold |
8,896
| – | – | 0.1% | 84 |
|
|
2014
Q4 | $857K | Buy |
8,896
+364
| +4% | +$32.1K | 0.09% | 86 |
|
|
2014
Q3 | $679K | Buy |
8,532
+339
| +4% | +$26.7K | 0.07% | 92 |
|
|
2014
Q2 | $618K | Buy |
8,193
+16
| +0.2% | +$1.21K | 0.07% | 95 |
|
|
2014
Q1 | $612K | Buy |
8,177
+1,174
| +17% | +$82.9K | 0.07% | 93 |
|
|
2013
Q4 | $501K | Buy |
7,003
+1,000
| +17% | +$64.3K | 0.06% | 98 |
|
|
2013
Q3 | $341K | Hold |
6,003
| – | – | 0.04% | 109 |
|
|
2013
Q2 | $343K | Buy |
+6,003
| New | +$348K | 0.05% | 109 |
|
Other funds holding CVS
ZWJ Investment Counsel's CVS Position: Q2 2024 in Review
ZWJ Investment Counsel sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,372 shares — an estimated $269K sold.
ZWJ Investment Counsel first reported a position in CVS in Q2 2013 and held it in 39 quarters. The position peaked at $24.2M in Q2 2017. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- ZWJ Investment Counsel reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- ZWJ Investment Counsel sold 3,372 CVS Health shares in Q2 2024, an estimated $269K.
- ZWJ Investment Counsel first reported a position in CVS Health in Q2 2013 and held it in 39 quarters.
- ZWJ Investment Counsel's CVS Health position peaked at $24.2M in Q2 2017.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on ZWJ Investment Counsel's 13F filing for Q2 2024, filed 19 Jul 2024.